According to a recent study, a straightforward blood test may be able to identify patients who are susceptible to long-term COVID.
Higher levels of leukocytes, a kind of white blood cell, are linked to more severe symptoms of long-term COVID in older women, according to a new study published on Wednesday in the journal of Menopause.
“Our findings suggest that leukocyte count, a well-standardized, stable, widely available, and inexpensive clinical marker of inflammation, is an independent predictor of future (long COVID) severity in postmenopausal women,” the team of researchers led by Ted Ng concluded.
According to UPI, samples from 1,200 women who took part in a COVID research study between June 2021 and February 2022 were used in the study.
